Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Nicotinamide adenine dinucleotide (NAD+) and its metabolites function as critical regulators
to maintain physiologic processes, enabling the plastic cells to adapt to environmental …
to maintain physiologic processes, enabling the plastic cells to adapt to environmental …
NAD+ in brain aging and neurodegenerative disorders
NAD+ is a pivotal metabolite involved in cellular bioenergetics, genomic stability,
mitochondrial homeostasis, adaptive stress responses, and cell survival. Multiple NAD+ …
mitochondrial homeostasis, adaptive stress responses, and cell survival. Multiple NAD+ …
Mitophagy and Alzheimer's disease: cellular and molecular mechanisms
Neurons affected in Alzheimer's disease (AD) experience mitochondrial dysfunction and a
bioenergetic deficit that occurs early and promotes the disease-defining amyloid beta …
bioenergetic deficit that occurs early and promotes the disease-defining amyloid beta …
NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency
Emerging findings suggest that compromised cellular bioenergetics and DNA repair
contribute to the pathogenesis of Alzheimer's disease (AD), but their role in disease-defining …
contribute to the pathogenesis of Alzheimer's disease (AD), but their role in disease-defining …
[HTML][HTML] Nicotinamide riboside—the current state of research and therapeutic uses
Nicotinamide riboside (NR) has recently become one of the most studied nicotinamide
adenine dinucleotide (NAD+) precursors, due to its numerous potential health benefits …
adenine dinucleotide (NAD+) precursors, due to its numerous potential health benefits …
Alzheimer's disease pathogenesis: Role of autophagy and mitophagy focusing in microglia
M Eshraghi, A Adlimoghaddam… - International Journal of …, 2021 - mdpi.com
Alzheimer's disease (AD) is a debilitating neurological disorder, and currently, there is no
cure for it. Several pathologic alterations have been described in the brain of AD patients …
cure for it. Several pathologic alterations have been described in the brain of AD patients …
Myelin in Alzheimer's disease: culprit or bystander?
M Maitre, H Jeltsch-David, NG Okechukwu… - Acta Neuropathologica …, 2023 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder with neuronal and synaptic
losses due to the accumulation of toxic amyloid β (Αβ) peptide oligomers, plaques, and …
losses due to the accumulation of toxic amyloid β (Αβ) peptide oligomers, plaques, and …
Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease
NM Shanbhag, MD Evans, W Mao, AL Nana… - Acta neuropathologica …, 2019 - Springer
The maintenance of genomic integrity is essential for normal cellular functions. However, it is
difficult to maintain over a lifetime in postmitotic cells such as neurons, in which DNA …
difficult to maintain over a lifetime in postmitotic cells such as neurons, in which DNA …
The role of PARP1 in neurodegenerative diseases and aging
K Mao, G Zhang - The FEBS journal, 2022 - Wiley Online Library
Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease
(PD), are characterized by progressive memory loss and motor impairment. Aging is a major …
(PD), are characterized by progressive memory loss and motor impairment. Aging is a major …
XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia
XRCC1 is a molecular scaffold protein that assembles multi-protein complexes involved in
DNA single-strand break repair,. Here we show that biallelic mutations in the human XRCC1 …
DNA single-strand break repair,. Here we show that biallelic mutations in the human XRCC1 …